These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3. Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A mBio; 2018 Nov; 9(6):. PubMed ID: 30425153 [TBL] [Abstract][Full Text] [Related]
23. Inconsistent reversal of HIV-1 latency ex vivo by antigens of HIV-1, CMV, and other infectious agents. Vollbrecht T; Angerstein AO; Menke B; Kumar NM; de Oliveira MF; Richman DD; Guatelli JC Retrovirology; 2020 Nov; 17(1):36. PubMed ID: 33228686 [TBL] [Abstract][Full Text] [Related]
24. Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells. Gadhamsetty S; Coorens T; de Boer RJ J Virol; 2016 Aug; 90(16):7066-7083. PubMed ID: 27226367 [TBL] [Abstract][Full Text] [Related]
25. Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load. Oxenius A; Günthard HF; Hirschel B; Fidler S; Weber JN; Easterbrook PJ; Bell JI; Phillips RE; Price DA Eur J Immunol; 2001 Apr; 31(4):1115-21. PubMed ID: 11298336 [TBL] [Abstract][Full Text] [Related]
27. Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8 Kwaa AKR; Talana CAG; Blankson JN J Virol; 2019 Feb; 93(3):. PubMed ID: 30404799 [TBL] [Abstract][Full Text] [Related]
28. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes. Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262 [TBL] [Abstract][Full Text] [Related]
29. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039 [TBL] [Abstract][Full Text] [Related]
30. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy. Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146 [TBL] [Abstract][Full Text] [Related]
31. Human immunodeficiency virus type 1 replication, immune activation, and circulating cytotoxic T cells against uninfected CD4+ T cells. Kottilil S; Gamberg J; Bowmer I; Trahey J; Howley C; Gallant M; Grant M J Clin Immunol; 2000 May; 20(3):175-86. PubMed ID: 10941825 [TBL] [Abstract][Full Text] [Related]
32. Latency Reversal 2.0: Giving the Immune System a Seat at the Table. Singh V; Dashti A; Mavigner M; Chahroudi A Curr HIV/AIDS Rep; 2021 Apr; 18(2):117-127. PubMed ID: 33433817 [TBL] [Abstract][Full Text] [Related]
33. BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo. Ren Y; Huang SH; Patel S; Alberto WDC; Magat D; Ahimovic D; Macedo AB; Durga R; Chan D; Zale E; Mota TM; Truong R; Rohwetter T; McCann CD; Kovacs CM; Benko E; Wimpelberg A; Cannon C; Hardy WD; Bosque A; Bollard CM; Jones RB J Clin Invest; 2020 May; 130(5):2542-2559. PubMed ID: 32027622 [TBL] [Abstract][Full Text] [Related]
34. Lack of correlation between phenotype activation markers of CD8 lymphocytes and cytotoxic T lymphocyte (CTL) function in HIV-1 infection: evidence for rescue with rIL-2. Chia WK; Nisbet-Brown E; Li X; Salit I; Joshi S; Read SE Viral Immunol; 1994; 7(2):81-95. PubMed ID: 7848511 [TBL] [Abstract][Full Text] [Related]
35. Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents. Gupta V; Dixit NM PLoS Comput Biol; 2018 Feb; 14(2):e1006004. PubMed ID: 29451894 [TBL] [Abstract][Full Text] [Related]
36. Thiostrepton Reactivates Latent HIV-1 through the p-TEFb and NF-κB Pathways Mediated by Heat Shock Response. Peng W; Hong Z; Chen X; Gao H; Dai Z; Zhao J; Liu W; Li D; Deng K Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094131 [TBL] [Abstract][Full Text] [Related]
37. Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4 Battivelli E; Dahabieh MS; Abdel-Mohsen M; Svensson JP; Tojal Da Silva I; Cohn LB; Gramatica A; Deeks S; Greene WC; Pillai SK; Verdin E Elife; 2018 May; 7():. PubMed ID: 29714165 [TBL] [Abstract][Full Text] [Related]
38. Proof-of-Principle for Immune Control of Global HIV-1 Reactivation In Vivo. Smith NM; Mlcochova P; Watters SA; Aasa-Chapman MM; Rabin N; Moore S; Edwards SG; Garson JA; Grant PR; Ferns RB; Kashuba A; Mayor NP; Schellekens J; Marsh SG; McMichael AJ; Perelson AS; Pillay D; Goonetilleke N; Gupta RK Clin Infect Dis; 2015 Jul; 61(1):120-8. PubMed ID: 25778749 [TBL] [Abstract][Full Text] [Related]
39. The role of latency reversal agents in the cure of HIV: A review of current data. Bashiri K; Rezaei N; Nasi M; Cossarizza A Immunol Lett; 2018 Apr; 196():135-139. PubMed ID: 29427743 [TBL] [Abstract][Full Text] [Related]
40. HIV Controllers Exhibit Effective CD8 Monel B; McKeon A; Lamothe-Molina P; Jani P; Boucau J; Pacheco Y; Jones RB; Le Gall S; Walker BD Cell Rep; 2019 Apr; 27(1):142-153.e4. PubMed ID: 30943397 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]